A (Agilent Tech) סך נכסי החברה

Agilent Technologies (A) seeks dominance in the chemistry and biopharma instrumentation segment by implementing a long-term service and software sales model. The business relies on the supply of consumables and equipment for environmental and medical applications, which mitigates industry risks. Mature chromatography solutions, which have become the global benchmark, provide a stable income stream. Total assets amount to 13090.91, as clearly demonstrated by this price chart.

For Agilent Technologies (A), the expansion of acid synthesis capacities and the automation of spectrometer assembly directly determine the dynamics of the resource base. A metric calculated inversely via ROA consolidates equity and liabilities to assess the overall business potential. Analyzing gross assets allows for the differentiation of organic growth from excessive inventory accumulation. Stable facility utilization confirms the efficiency of property complex management amid inflationary pressures.